Quantcast

Latest Tibotec Stories

2015-03-19 04:22:13

Investigational Anti-thrombin Antibody Ichorcumab Strengthens Cardiovascular Disease Portfolio RARITAN, N.J., March 19, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc.

2014-08-25 08:27:57

Clinical Candidate COVA 322 and FynomAb® Technology Platform Further Strengthen Immunology Portfolio and Capabilities ZUG, Switzerland, Aug.

2012-12-01 05:03:02

New research report “KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen” elaborated by FirstWord has been recently published by Market Publishers Ltd.

2011-07-06 06:00:00

HUDDINGE, Sweden, July 6, 2011 /PRNewswire/ -- Medivir AB (OMX: MVIR), is an emerging research-based specialty pharmaceutical company focused on infectious diseases. Medivir today announced that its investigational protease inhibitor TMC435 has received "Fast Track" designation by the U.S.


Word of the Day
coruscant
  • Emitting flashes of light; glittering.
The word 'coruscant' comes from a Latin word meaning 'to flash' or 'to sparkle'.
Related